TX-MARY-KAY
21.11.2023 18:04:33 CET | Business Wire | Press release
Mary Kay Inc., a global beauty brand and advocate for women’s empowerment, is excited to announce its membership in the Global Shea Alliance (GSA), a non-profit industry association that designs, develops and delivers strategies that drive a competitive and sustainable shea industry worldwide. This new partnership aligns with Mary Kay's commitment to sustainability and its mission to empower women around the world.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231121605161/en/
“This partnership marks a significant step in our journey to promote sustainable beauty practices. By collaborating with the Global Shea Alliance, we aim to further harness the transformative potential of shea in skincare and cosmetics," said Deborah Gibbins, Chief Operating Officer at Mary Kay. (Credit: Mary Kay Inc.).
The GSA's core values are founded on promoting an inclusive value chain, fostering a pre-competitive and business-driven industry by ensuring sustainability and maintaining confidentiality in all transactions with its stakeholders.
“We are absolutely thrilled to join the Global Shea Alliance,” said Deborah Gibbins, Chief Operating Officer at Mary Kay. “This partnership marks a significant step in our journey to promote sustainable beauty practices. By collaborating with the GSA, we aim to further harness the transformative potential of shea in skincare and cosmetics.”
Mamatou Djaffo, President of the Global Shea Alliance, expressed her enthusiasm about the new partnership. “We extend a heartfelt welcome to Mary Kay Inc,” said Mamatou Djaffo. “Their stellar reputation as champions of corporate social responsibility and sustainability perfectly aligns with our mission. We are thrilled at the prospect of collaborating with Mary Kay to drive substantial positive change within the cosmetics industry. Together, we aim to establish new industry standards for social and environmental responsibility, transcending beauty to empower individuals, promote sustainability, and foster a more resilient future for the millions of women who depend on shea.”
This exciting partnership between Mary Kay Inc. and the Global Shea Alliance in the upcoming year will spearhead initiatives aimed at enhancing the economic well-being of shea collectors and processors, as well as undertaking crucial efforts to restore degraded parklands in West Africa.
Earlier this month, Mary Kay hosted Aaron Adu, GSA Managing Director, and Olawunmi Osholake, GSA Deputy Managing Director, at its manufacturing facility, the Richard R. Rogers (R3) Manufacturing / R&D Center in Lewisville, Texas, U.S.A. for a site visit followed by a meeting exploring synergies and engagement opportunities.
About Mary Kay
Then. Now. Always. One of the original glass ceiling breakers, Mary Kay Ash founded her dream beauty brand in Texas in 1963 with one goal: to enrich women’s lives. That dream has blossomed into a global company with millions of independent sales force members in more than 35 countries. For 60 years, the Mary Kay opportunity has empowered women to define their own futures through education, mentorship, advocacy, and innovation. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skincare, color cosmetics, nutritional supplements, and fragrances. Mary Kay believes in preserving our planet for future generations, protecting women impacted by cancer and domestic abuse and encouraging youth to follow their dreams. Learn more at marykayglobal.com, find us on Facebook, Instagram and LinkedIn, or follow us on X (formerly known as Twitter).
About Global Shea Alliance
The GSA is a non-profit industry association with 919 members from 39 countries including women collectors and processors, brands and retailers, ingredient suppliers, civil society, research institutions and policymakers. Through public-private partnerships, the GSA promotes industry sustainability, quality practices and standards and demand for shea in food and cosmetics. For more information, please visit https://globalshea.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231121605161/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alsym Energy Announces Na-Series Battery Success Developed With Physics-Informed AI Platform27.4.2026 21:25:00 CEST | Press release
Alsym’s proprietary physics-informed AI platform powered the development of its Na-Series batteries—a non-flammable, high performance and low cost energy solution positioned to serve critical energy storage markets including data centers, utilities, telecommunications, commercial real estate, industrial and defense, among others. Alsym Energy, a pioneer in non-flammable, high-performance sodium-ion batteries, today announced details of the proprietary physics-informed AI platform used to develop the company’s recently launched Na-Series sodium-ion batteries. By integrating fundamental physics models with AI, autonomous testing and proprietary molecular diagnostics in a closed-loop system, Alsym is accelerating the design of safer, inexpensive, commercialized batteries through all phases of the development cycle. As global demand for electricity surges, the limitations of lithium-ion batteries have become increasingly apparent, particularly around safety and supply chain constraints. Li
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release
As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release
Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release
Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom